Physician

Agnieszka G Cantre

According to 2025 Medicare claims, Agnieszka Cantre (NPI: 1356463897) practices ophthalmology in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is OPHTHALMOLOGY PARTNERS, LTD. (NPI: 1750423463; TIN: 36-3144752) and primary practice location at 60015-4472.

Cantre's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 496 traditional Medicare patients, billed 1,361 HCPCS/CPT codes, and received $110,214 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 602 prescription claims across 178 beneficiaries totaling $44,435 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 3 records totaling $61. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $53,828 to $44,435. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$55K$110K2020 Medicare payment: $55,250 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $64,470 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $59,075 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $77,021 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $110,214 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020229632$55,250
2021241712$64,470
2022211583$59,075
2023398968$77,021
20244961,361$110,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$62K$125K2015 Drug cost: $53,828 (USD; Tot_Drug_Cst)2016 Drug cost: $58,848 (USD; Tot_Drug_Cst)2017 Drug cost: $108,117 (USD; Tot_Drug_Cst)2018 Drug cost: $124,682 (USD; Tot_Drug_Cst)2019 Drug cost: $86,521 (USD; Tot_Drug_Cst)2020 Drug cost: $23,634 (USD; Tot_Drug_Cst)2021 Drug cost: $27,757 (USD; Tot_Drug_Cst)2022 Drug cost: $30,406 (USD; Tot_Drug_Cst)2023 Drug cost: $24,248 (USD; Tot_Drug_Cst)2024 Drug cost: $44,435 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153471,032$53,828
2016316967$58,848
20175061,695$108,117
20185211,659$124,682
20193751,103$86,521
2020160447$23,634
2021131470$27,757
2022133456$30,406
2023142322$24,248
2024178602$44,435

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more335379$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more228432$67
92083Exam of visual field with extended testing5864$46
92134Imaging of retina8098$30
92133Imaging of optic nerve7277$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine14480$9,840
Timolol MaleateTimolol Maleate744,647$3,363
Brimonidine TartrateBrimonidine Tartrate342,209$2,120
Tobramycin-DexamethasoneTobramycin/Dexamethasone431,486$1,875
Prednisolone AcetatePrednisolone Acetate471,173$1,490

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$61ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Agnieszka G. Cantre?

Tedicare shows public-source Medicare data for Agnieszka G. Cantre (NPI 1356463897), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Agnieszka G. Cantre have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Agnieszka G. Cantre?

Agnieszka G. Cantre is linked to OPHTHALMOLOGY PARTNERS, LTD. (billing NPI 1750423463) in the available physician profile data.

Does Agnieszka G. Cantre have Open Payments data?

Agnieszka G. Cantre has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.